A Study Evaluating Safety, Pharmacokinetics, Pharmacodynamics, And Clinical Activity Of RO7119929 (TLR7 Agonist) In Participants With Unresectable Advanced Or Metastatic Hepatocellular Carcinoma, Biliary Tract Cancer, Or Solid Tumors With Hepatic Metastases
Phase 1 Completed
55 enrolled 30 charts
Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer
Phase 1 Completed
29 enrolled
A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer
Phase 1 Completed
175 enrolled 23 charts
ABC-08
Phase 1 Completed
21 enrolled
SOLAR
Phase 1 Completed
18 enrolled
A Phase I, Open-Label, Multicentre Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MEDI4736 in Patients With Advanced Solid Tumours
Phase 1 Completed
269 enrolled
A Study of ARRY-438162 (MEK162) in Patients With Advanced Cancer
Phase 1 Completed
93 enrolled
IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread
Phase 1 Completed
22 enrolled 15 charts
A Study to Assess the Safety, Tolerability and Anti-tumour Activity of Ascending Doses of Selumetinib in Combination With MEDI4736 and Selumetinib in Combination With MEDI4736 and Tremelimumab in Patients With Advanced Solid Tumours
Phase 1 Completed
58 enrolled
A Study of Varlitinib in Japanese Subjects With Advanced or Metastatic Solid Tumours
Phase 1 Completed
24 enrolled
A Phase I Study of Adjuvant Chemotherapy With GC in Biliary Tract Cancer Undergoing Resection Without Major Hepatectomy
Phase 1 Completed
24 enrolled
A Phase I Study of Adjuvant Chemotherapy With GS in Biliary Tract Cancer Undergoing Resection Without Major Hepatectomy
Phase 1 Completed
38 enrolled
ABC-04
Phase 1 Completed
13 enrolled
Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors
Phase 1 Completed
23 enrolled
Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers
Phase 1 Completed
45 enrolled